# OnCo record fluoroestradiol-f18 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/fluoroestradiol-f18/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "fluoroestradiol-f18" ;
  schema:name "Fluoroestradiol F-18 (FES PET)"@en ;
  schema:description "A PET scan that shows which breast cancer deposits still have oestrogen receptors, helping decide whether hormone therapy will work when biopsy is impractical."@en ;
  schema:url <https://onco.cc/drugs/fluoroestradiol-f18/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Fluoroestradiol_F-18> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Cerianna> ;
  onco:status "approved" ;
  onco:tag "gap-fill", "diagnostic" ;
  onco:modality "PET radiotracer (oestrogen receptor ligand)" ;
  schema:alternateName "Cerianna" ;
  onco:approval "US 2020: Detection of ER-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/pet/>, <https://onco.cc/technologies/pet-ct/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/> ;
  onco:companies <https://onco.cc/companies/ge-healthcare/> ;
  onco:trials <https://onco.cc/trials/nct04692103/>, <https://onco.cc/trials/nct02398773/>, <https://onco.cc/trials/nct06260033/> .